Mark Elliott Boulding Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark Elliott Boulding.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark Elliott Boulding. Mark Elliott Boulding is Exec VP and CLO in PTC THERAPEUTICS, INC. ($PTCT) and Exec. VP and CLO in PTC THERAPEUTICS, INC. ($PTCT).

Latest Insider Trading Transactions of Mark Elliott Boulding

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 08 2021	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	A	66.49	59,500	3,956,155	59,500
Jan 08 2021	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Grant	A	0.00	10,200	0	49,152	39 K to 49.2 K (+26.19 %)
Jan 07 2021	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	62.37	772	48,150	38,952	39.7 K to 39 K (-1.94 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	18.01	17,500	315,175	26,250
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	11.23	13,125	147,394	6,563
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.73	100	5,573	39,724	39.8 K to 39.7 K (-0.25 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.24	3,675	203,011	39,824	43.5 K to 39.8 K (-8.45 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	54.20	600	32,517	43,499	44.1 K to 43.5 K (-1.36 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.74	400	22,295	44,099	44.5 K to 44.1 K (-0.90 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.23	7,350	405,955	44,499	51.8 K to 44.5 K (-14.18 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	54.20	1,000	54,202	51,849	52.8 K to 51.8 K (-1.89 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.26	3,775	208,591	52,849	56.6 K to 52.8 K (-6.67 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	54.20	600	32,517	56,624	57.2 K to 56.6 K (-1.05 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	18.01	17,500	315,175	57,224	39.7 K to 57.2 K (+44.05 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.73	200	11,146	39,724	39.9 K to 39.7 K (-0.50 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.23	4,301	237,536	39,924	44.2 K to 39.9 K (-9.73 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	54.18	626	33,916	44,225	44.9 K to 44.2 K (-1.40 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.24	2,881	159,144	44,851	47.7 K to 44.9 K (-6.04 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	54.15	400	21,659	47,732	48.1 K to 47.7 K (-0.83 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.73	100	5,573	48,132	48.2 K to 48.1 K (-0.21 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.22	2,824	155,953	48,232	51.1 K to 48.2 K (-5.53 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	54.11	357	19,317	51,056	51.4 K to 51.1 K (-0.69 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	55.31	962	53,205	51,413	52.4 K to 51.4 K (-1.84 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	54.70	474	25,927	52,375	52.8 K to 52.4 K (-0.90 %)
Jul 09 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	11.23	13,125	147,394	52,849	39.7 K to 52.8 K (+33.04 %)
Jan 31 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	A	51.16	59,500	3,044,020	59,500
Jan 31 2020	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Grant	A	0.00	10,200	0	39,724	29.5 K to 39.7 K (+34.55 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	18.01	4,375	78,794	43,750
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	18.01	4,375	78,794	48,125
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	11.23	3,281	36,846	19,688
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	11.23	3,281	36,846	22,969
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.34	1,441	65,329	29,524	31 K to 29.5 K (-4.65 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	44.45	2,934	130,428	30,965	33.9 K to 31 K (-8.66 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	18.01	4,375	78,794	33,899	29.5 K to 33.9 K (+14.82 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.31	1,399	63,394	29,524	30.9 K to 29.5 K (-4.52 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	44.46	2,976	132,313	30,923	33.9 K to 30.9 K (-8.78 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	18.01	4,375	78,794	33,899	29.5 K to 33.9 K (+14.82 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.34	1,098	49,787	29,524	30.6 K to 29.5 K (-3.59 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	44.46	2,183	97,047	30,622	32.8 K to 30.6 K (-6.65 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	11.23	3,281	36,846	32,805	29.5 K to 32.8 K (+11.11 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.34	1,000	45,342	29,524	30.5 K to 29.5 K (-3.28 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	44.48	2,281	101,457	30,524	32.8 K to 30.5 K (-6.95 %)
Jul 09 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	11.23	3,281	36,846	32,805	29.5 K to 32.8 K (+11.11 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	18.01	17,500	315,175	52,500
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	11.23	2,142	24,055	26,250
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	27.05	70,849	1,916,465	0
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	27.05	7,307	197,654	70,849
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	10.85	384	4,166	0
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	10.85	5,910	64,124	0
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	11.23	1,140	12,802	28,392
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	11.23	22,968	257,931	29,532
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	27.05	1,844	49,880	78,156
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	10.85	44,090	478,377	5,910
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	M	10.85	7,533	81,733	384
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	17,500	787,500	29,524	47 K to 29.5 K (-37.22 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	18.01	17,500	315,175	47,024	29.5 K to 47 K (+59.27 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	2,142	96,390	29,524	31.7 K to 29.5 K (-6.76 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	11.23	2,142	24,055	31,666	29.5 K to 31.7 K (+7.26 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	70,849	3,188,205	29,524	100.4 K to 29.5 K (-70.59 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	27.05	70,849	1,916,465	100,373	29.5 K to 100.4 K (+239.97 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	7,307	328,815	29,524	36.8 K to 29.5 K (-19.84 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	27.05	7,307	197,654	36,831	29.5 K to 36.8 K (+24.75 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	384	17,280	29,524	29.9 K to 29.5 K (-1.28 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	10.85	384	4,166	29,908	29.5 K to 29.9 K (+1.30 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	5,910	265,950	29,524	35.4 K to 29.5 K (-16.68 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	10.85	5,910	64,124	35,434	29.5 K to 35.4 K (+20.02 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	1,140	51,300	29,524	30.7 K to 29.5 K (-3.72 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	11.23	1,140	12,802	30,664	29.5 K to 30.7 K (+3.86 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	22,968	1,033,560	29,524	52.5 K to 29.5 K (-43.76 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	11.23	22,968	257,931	52,492	29.5 K to 52.5 K (+77.79 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	1,844	82,980	29,524	31.4 K to 29.5 K (-5.88 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	27.05	1,844	49,880	31,368	29.5 K to 31.4 K (+6.25 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	44,090	1,984,050	29,524	73.6 K to 29.5 K (-59.89 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	10.85	44,090	478,377	73,614	29.5 K to 73.6 K (+149.34 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	45.00	7,533	338,985	29,524	37.1 K to 29.5 K (-20.33 %)
Jul 02 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Buy	M	10.85	7,533	81,733	37,057	29.5 K to 37.1 K (+25.51 %)
Jan 24 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	A	33.02	17,500	577,850	17,500
Jan 24 2019	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	A	33.02	72,500	2,393,950	72,500
Jan 05 2018	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	A	18.01	70,000	1,260,700	70,000
Jan 05 2017	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	A	11.23	52,500	589,575	52,500
Jan 05 2017	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Grant	A	0.00	9,000	0	27,034	18 K to 27 K (+49.91 %)
Jan 06 2016	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	A	30.86	70,000	2,160,200	70,000
Jun 10 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec VP and CLO	Option Exercise	M	10.85	50,000	542,500	50,000
Jun 10 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec VP and CLO	Option Exercise	M	10.85	12,083	131,101	7,917
Jun 10 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec VP and CLO	Sell	S	56.42	3,140	177,159	16,327	19.5 K to 16.3 K (-16.13 %)
Jun 10 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec VP and CLO	Sell	S	55.62	24,609	1,368,753	19,467	44.1 K to 19.5 K (-55.83 %)
Jun 10 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec VP and CLO	Sell	S	54.70	18,324	1,002,323	44,076	62.4 K to 44.1 K (-29.37 %)
Jun 10 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec VP and CLO	Sell	S	53.87	10,776	580,503	62,400	73.2 K to 62.4 K (-14.73 %)
Jun 10 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec VP and CLO	Buy	M	10.85	50,000	542,500	73,176	23.2 K to 73.2 K (+215.74 %)
Jun 10 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec VP and CLO	Buy	M	10.85	12,083	131,101	23,176	11.1 K to 23.2 K (+108.92 %)
Mar 23 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	69.77	142	9,907	11,093	11.2 K to 11.1 K (-1.26 %)
Mar 23 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	68.72	7,547	518,630	11,235	18.8 K to 11.2 K (-40.18 %)
Mar 23 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	67.77	13,453	911,710	18,782	32.2 K to 18.8 K (-41.73 %)
Jan 02 2015	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Option Exercise	A	51.00	85,600	4,365,600	85,600
Mar 21 2014	PTCT	PTC THERAPEUTICS, ...	Boulding Mark Elliott	Exec. VP and CLO	Sell	S	30.96	10,049	311,117	32,235	42.3 K to 32.2 K (-23.77 %)

Page: 1